AAAAAA

   
Results: 1-9 |
Results: 9
Influence of acyl chain fluidity on the lipopolysaccharide-induced activation of complement
Authors: Wiese, A Grunewald, P Schaper, KJ Seydel, U
Citation: A. Wiese et al., Influence of acyl chain fluidity on the lipopolysaccharide-induced activation of complement, J ENDOTOX R, 7(2), 2001, pp. 147-155
pH-dependent partitioning of acidic and basic drugs into liposomes - A quantitative structure-activity relationship analysis
Authors: Schaper, KJ Zhang, HB Raevsky, OA
Citation: Kj. Schaper et al., pH-dependent partitioning of acidic and basic drugs into liposomes - A quantitative structure-activity relationship analysis, QSAR, 20(1), 2001, pp. 46-54
N-1-hetarylcarbonyl substituted amidrazones and 3,5-disubstituted 1,2,4-triazoles as potential antimyco-bacterial agents
Authors: Ranft, D Lehwark-Yvetot, G Schaper, KJ Buge, A
Citation: D. Ranft et al., N-1-hetarylcarbonyl substituted amidrazones and 3,5-disubstituted 1,2,4-triazoles as potential antimyco-bacterial agents, PHARMAZIE, 56(3), 2001, pp. 266-266
Synthesis and structure-activity relationships of a new model of arylpiperazines. 6. Study of the 5-HT1A/alpha(1)-adrenergic receptor affinity by classical Hansch analysis, artificial neural networks, and computational simulation of ligand recognition
Authors: Lopez-Rodriguez, ML Morcillo, MJ Fernandez, E Rosado, ML Pardo, L Schaper, KJ
Citation: Ml. Lopez-rodriguez et al., Synthesis and structure-activity relationships of a new model of arylpiperazines. 6. Study of the 5-HT1A/alpha(1)-adrenergic receptor affinity by classical Hansch analysis, artificial neural networks, and computational simulation of ligand recognition, J MED CHEM, 44(2), 2001, pp. 198-207
Quantitative estimation of drug absorption in humans for passively transported compounds on the basis of their physico-chemical parameters
Authors: Raevsky, OA Fetisov, VI Trepalina, EP McFarland, JW Schaper, KJ
Citation: Oa. Raevsky et al., Quantitative estimation of drug absorption in humans for passively transported compounds on the basis of their physico-chemical parameters, QSAR, 19(4), 2000, pp. 366-374
Design and synthesis of 2-[4-[4-(m-(ethylsulfonamido)-phenyl)piperazin-1-yl]butyl]-1,3-dioxoperhydropyrrolo[1,2-c]imidazole (EF-7412) using neural networks. A selective derivative with mixed 5-HT1A/D-2 antagonist properties
Authors: Lopez-Rodriguez, ML Morcillo, MJ Fernandez, E Rosado, ML Orensanz, L Beneytez, ME Manzanares, J Fuentes, JA Schaper, KJ
Citation: Ml. Lopez-rodriguez et al., Design and synthesis of 2-[4-[4-(m-(ethylsulfonamido)-phenyl)piperazin-1-yl]butyl]-1,3-dioxoperhydropyrrolo[1,2-c]imidazole (EF-7412) using neural networks. A selective derivative with mixed 5-HT1A/D-2 antagonist properties, BIOORG MED, 9(12), 1999, pp. 1679-1682
Free-Wilson-type analysis of non-additive substituent effects on THPB dopamine receptor affinity using artificial neural networks
Authors: Schaper, KJ
Citation: Kj. Schaper, Free-Wilson-type analysis of non-additive substituent effects on THPB dopamine receptor affinity using artificial neural networks, QSAR, 18(4), 1999, pp. 354-360
Substituted xanthones as antimycobacterial agents Part 3: QSAR investigations
Authors: Schaper, KJ Pickert, M Frahm, AW
Citation: Kj. Schaper et al., Substituted xanthones as antimycobacterial agents Part 3: QSAR investigations, ARCH PHARM, 332(3), 1999, pp. 91-102
New N-1-hetarylmethylene-substituted amidrazones with potential antimycobacterial activity
Authors: Ranft, D Seyfarth, T Schaper, KJ Lehwark-Yvetot, G Bruhn, C Buge, A
Citation: D. Ranft et al., New N-1-hetarylmethylene-substituted amidrazones with potential antimycobacterial activity, ARCH PHARM, 332(12), 1999, pp. 427-430
Risultati: 1-9 |